Product
zoliflodacin
1 clinical trial
1 indication
Indication
GonorrheaClinical trial
A Multi-center, Randomized, Open-label, Non Inferiority Trial to Evaluate the Efficacy and Safety of a Single, Oral Dose of Zoliflodacin Compared to a Combination of a Single Intramuscular Dose of Ceftriaxone and a Single Oral Dose of Azithromycin in the Treatment of Patients With Uncomplicated GonorrhoeaStatus: Active (not recruiting), Estimated PCD: 2023-08-30